Physician

Abdallah I Kafrouni, M.D.

According to 2025 Medicare claims, Abdallah Kafrouni, M.D. (NPI: 1831284645) practices pulmonary disease in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Duval, FL. This provider's primary affiliated billing organization is ST VINCENTS AMBULATORY CARE INC (NPI: 1417987124; TIN: 592292041) and primary practice location at 32204-4748. Kafrouni is affiliated with the St Vincents Accountable Care Organization LLC (ACO ID: A2205), participating under the MSSP model.

Kafrouni's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 342 traditional Medicare patients, billed 575 HCPCS/CPT codes, and received $63,050 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 63 prescription claims across 13 beneficiaries totaling $15,024 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 549 claims. Open Payments data shows 4 records totaling $281. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $130,925 to $63,050. Similarly, Part D prescription costs have declined steadily, from $19,725 to $15,024. For DME billing, reported payments fell sharply in recent years, from $31,796 to $28,434.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	433	1,062	$130,925
2016	446	1,026	$115,089
2017	304	634	$78,229
2018	322	561	$65,527
2019	321	568	$64,999
2020	263	498	$61,493
2021	278	493	$57,714
2022	279	543	$56,656
2023	376	817	$93,792
2024	342	575	$63,050

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	23	98	$19,725
2016	35	105	$22,450
2017	29	89	$28,600
2018	25	83	$34,896
2019	20	53	$15,149
2020	12	52	$11,627
2021	12	20	$4,751
2022	N/R	27	$8,811
2023	11	26	$1,202
2024	13	63	$15,024

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	379	801	$27,339
2016	412	854	$29,782
2017	420	987	$27,985
2018	444	964	$27,577
2019	423	891	$27,253
2020	354	816	$27,883
2021	251	543	$16,548
2022	154	340	$10,173
2023	147	355	$12,614
2024	287	549	$24,882

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	94	193	$167
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	61	77	$92
95811	Sleep study in sleep lab with continuous airway pressure (6 years or older)	43	44	$91
95810	Sleep study in sleep lab (6 years or older)	71	72	$79
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	33	38	$68

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	660	$13,847
Albuterol Sulfate Hfa	Albuterol Sulfate	23	725	$832

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0471	Respiratory assist device, bi-level pressure capability, with back-up rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	18	$3,588
A7030	Full face mask used with positive airway pressure device, each	N	23	41	$3,349
A7031	Face mask interface, replacement for full face mask, each	N	22	42	$3,048
E0601	Continuous positive airway pressure (cpap) device	Y	14	82	$2,618
A7032	Cushion for use on nasal mask interface, replacement only, each	N	17	26	$2,354

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$281	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdallah I. Kafrouni, M.D.?

Tedicare shows public-source Medicare data for Abdallah I. Kafrouni, M.D. (NPI 1831284645), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdallah I. Kafrouni, M.D. have ACO affiliation data?

Abdallah I. Kafrouni, M.D. is shown with ACO affiliation data for St Vincents Accountable Care Organization LLC (MSSP, ACO ID A2205).

What billing organization is linked to Abdallah I. Kafrouni, M.D.?

Abdallah I. Kafrouni, M.D. is linked to ST VINCENTS AMBULATORY CARE INC (billing NPI 1417987124) in the available physician profile data.

Does Abdallah I. Kafrouni, M.D. have Open Payments data?

Abdallah I. Kafrouni, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.